申请人:BELLBROOK LABS, LLC
公开号:US20220073470A1
公开(公告)日:2022-03-10
This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating or preventing inappropriate activation of a type I interferon (IFN) response in a subject in need thereof.